Published in Women's Health Weekly, April 1st, 2004
According to a study from France, "first cause of hyperthyroidism among women of childbearing age, Graves' disease raises the risk of maternal and fetal complications, including eclampsia, cardiac failure, abortion, prematurity, fetal death, all of which can be avoided if maternal hyperthyroidism is closely controlled."
"The risk of transplacental hyperthyroidism has been shown to correlate to the titer of anti-thyroid stimulating hormone (TSH) receptor antibodies and has to be evaluated not only in women treated for Graves' disease during pregnancy, but also in women who...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.